🇺🇸

US SEC Filing Intelligence

· daily

US Material Events SEC 8-K Filings — May 19, 2026

The May 19, 2026, filing batch reveals a market dominated by capital structure maneuvers, with a clear bifurcation between companies aggressively refinancing or raising debt (Blackstone Mortgage Trust, Sabre Corp, Humana, Southwest Airlines) and those executing strategic M&A or asset sales (Permian Resources, Bank First Corp, GoPro). Insider activity is largely absent from these filings, shifting focus to capital allocation signals: share buybacks (HF Sinclair) and debt-for-equity swaps (Jaguar Health) indicate varied financial health. A significant undercurrent is the wave of shareholder dissent on compensation plans, with several companies (DHI Group, ACCO Brands, Permian Resources) seeing notable 'against' votes, signaling potential governance friction. Forward-looking data points to key catalysts in H2 2026, including Phase 3 readouts for Immunic and pivotal trial enrollment for Nexalin. Overall, the digest points to a market where liquidity management and strategic pivots are paramount, with governance issues emerging as a key risk factor.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 19, 2026

The May 19, 2026 filing batch for the Dow 30 stream reveals a market bifurcated between resilient consumer-facing giants and deeply distressed smaller entities. The dominant theme is margin compression, with Home Depot reporting a 100 bps operating margin decline despite 4.8% revenue growth, while CAVA Group's 32.2% revenue surge was overshadowed by a net income drop. A significant M&A wave is cresting, with the $2.2B Publicis/LiveRamp deal and Thermon/CECO merger creating actionable catalysts, though Two Harbors' adjourned shareholder vote signals deal execution risk. The most alarming trend is the cash burn across the portfolio: Energy Vault's cash used in operations surged 20x to $53.8M, Sono Group posted negative equity, and Ehave's losses widened 31.6% with only $2,183 in revenue. Insider activity is sparse but telling, with no major insider buying detected, while the restatement at Driven Brands ($77M cumulative EBITDA hit) and the PFIC warning from 36Kr represent significant governance and tax risks. The opportunity set lies in the M&A arbitrage (LiveRamp at $38.50/sh) and the turnaround plays at Novelis (Oswego restart) and CAVA (raised guidance), but the overall tone is cautious, favoring quality and liquidity.

11 high priority 39 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 19, 2026

Today's digest reveals a market bifurcated between robust operational growth in select industrials and energy transition plays, and deepening financial distress in several small-cap and micro-cap names. Key themes include a flurry of SPAC activity with both high-profile deals (Einride, Pasqal) and deadline extensions (Plum IV) signaling execution risk, while capital-intensive sectors like cement and data centers show strong volume growth but margin compression. Notable distress signals emerge from Natural Alternatives, Ehave, and TechPrecision, where cash burn, covenant pressure, and related-party financing are acute. Insider activity is limited but notable: GitLab's chair converted all super-voting shares for tax planning, while Home Depot's reaffirmed guidance provides a steady anchor. The day is rich with forward-looking catalysts, including upcoming shareholder votes for the Thermon/CECO merger and Einride's de-SPAC, and a slate of IPOs from foreign issuers with governance risks. Overall, the data suggests a 'barbell' market where high-quality growth and distressed assets coexist, demanding selective positioning.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 19, 2026

The 50 filings for the S&P 500 Consumer Discretionary stream on May 19, 2026, reveal a sector bifurcated between strong top-line growth and margin compression. Home Depot's Q1 results exemplify this, with sales up 4.8% YoY but net earnings down 4.2% and operating margins contracting 100 bps, leading to a reaffirmed but cautious full-year guidance. The most significant capital allocation signal comes from HF Sinclair Corp, which executed its 21st share repurchase from a single holder, totaling $717M of a $1B program, indicating a strong commitment to returning capital. M&A activity is concentrated in the financial and energy sectors, with Bank First Corp's $202.9M all-stock acquisition of PSB Holdings and the proposed business combination for Permian Basin Royalty Trust, both carrying execution risk. Insider activity is notably absent across consumer discretionary names, but several SPACs (FortuneX, FG Merger III) are actively seeking targets, creating a pipeline of potential future transactions. The most critical risk is the accounting restatement at BestGofer Inc., which revealed a $78,754 goodwill impairment and a 12x increase in net loss, a severe red flag for micro-cap governance. Overall, the sector shows resilience in demand but faces profitability headwinds, with investors favoring companies that demonstrate clear capital return policies and operational efficiency.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 19, 2026

The 42 filings for the S&P 500 Healthcare sector reveal a sector in transition, with significant capital market activity (IPOs, SPACs, debt offerings) and strategic repositioning (M&A, name changes, C-suite transitions) overshadowing operational results. Key period-over-period trends from the limited operational data available show a stark divergence: Cisco's 12% revenue growth and 35% net income surge contrast sharply with BioForce Nanosciences' continued revenue-less losses and Parabilis Medicines' widening net losses of $145.9M. The most critical developments include Parabilis Medicines' IPO filing with a concurrent $75M Regeneron private placement, signaling strong strategic interest in its pipeline, and Humana's $1.5B P-Caps issuance, a complex capital management move. Insider activity is notably absent across the healthcare filings, but the high volume of capital allocation events (debt offerings, buybacks, IPO filings) suggests a sector actively managing its balance sheet and growth trajectory. Portfolio-level patterns indicate a focus on liquidity management (TechPrecision's credit extension, Humana's P-Caps) and a cautious but present appetite for growth capital (Parabilis IPO, Energy Transition SPAC IPO).

13 high priority 29 medium 42 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 19, 2026

The three proxy filings reveal a period of corporate governance evolution and strategic realignment, with a notable absence of aggressive executive compensation changes. The dominant theme is the restructuring of advisory relationships, as seen in RBB Fund's proposal to add a co-adviser, which is a non-financial event for shareholders but signals operational consolidation in the asset management space. iAnthus Capital's filing is a routine governance exercise post-recapitalization, with no new compensation data, while MongoDB's proxy focuses on governance modernization (eliminating supermajority voting) and standard director elections, with no disclosed changes to executive pay. Across all three, there is a lack of period-over-period compensation trends, insider trading activity, or forward-looking financial guidance, limiting the depth of quantitative signals. The most actionable insights stem from the scheduled shareholder meetings and governance proposals, which provide near-term catalysts for monitoring shareholder sentiment and potential activist involvement. The overall sentiment is neutral, with materiality ranging from low (MongoDB) to moderate (RBB Fund), reflecting the routine nature of these filings.

3 high priority 3 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 19, 2026

The IPO pipeline on May 19, 2026, presents a highly polarized landscape, ranging from a development-stage interior design company with a going concern warning to a biotech firm with a $75M strategic investment from Regeneron. The most significant period-over-period trend is the escalating cash burn at Parabilis Medicines, where net losses widened 24% YoY to $145.9M, contrasting sharply with the nascent stage of Lawaken Group, whose CEO compensation surged 531% YoY to $1.85M despite a lack of employee benefits. A notable capital allocation pattern emerges with JAB Acquisition Corp I raising $150M in a SPAC IPO, signaling continued appetite for blank-check vehicles targeting tech, healthcare, and logistics. The absence of insider trading data across all filings is a critical gap, limiting conviction signals. The most actionable development is Regeneron's $75M private placement in Parabilis at a 10% discount to the IPO price, which provides a strong validation signal but also creates a potential overhang. The pipeline is dominated by high-risk, early-stage issuers, with 3 of 5 filings showing negative or going-concern sentiment, suggesting a cautious market reception ahead.

5 high priority 5 total filings
· daily

Global High-Priority Regulatory Events — May 19, 2026

The 50 filings from May 19, 2026, reveal a market dominated by capital return events (buybacks/dividends) and significant M&A/de-SPAC activity, but with underlying financial stress in several sectors. A clear theme is the aggressive return of capital to shareholders, with Dhanuka Agritech, Zydus Lifesciences, Welspun Living, and Sarla Performance Fibers announcing buybacks totaling over ₹1,466 crore, signaling strong balance sheets and management confidence. However, this is contrasted by severe financial distress in the US small-cap space, where Natural Alternatives International (NAII) reported a 79% gross profit collapse and TechPrecision Corp secured only a 4-month credit extension, highlighting acute liquidity pressures. The M&A landscape is active but mixed; the Einride/Legato de-SPAC is progressing with a $1.35B valuation and a June 4 vote, while the Permian Basin Royalty Trust deal remains non-binding and the Plum/Controlled Thermal merger faces delays. Insider activity is sparse but notable, with a significant 2.9M share sale by Invesco in Delhivery and a promoter pledge exceeding 50% at Damodar Industries, both bearish signals. Overall, the digest points to a bifurcated market: cash-rich companies are rewarding shareholders, while others face existential refinancing risks and operational deterioration.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 19, 2026

The 36 filings from May 19, 2026, reveal a bifurcated market where top-line growth is often masking underlying margin compression and cash flow deterioration. A clear theme is 'growth at a cost,' with companies like Cisco (12% revenue growth) and Energy Vault (156% revenue growth) showing strong sales but facing margin pressure or widening losses. Conversely, several micro-cap and pre-revenue companies (e.g., ShorePower, RMX Industries) are experiencing severe revenue declines and cash burn, signaling distress. Insider activity is notably absent from the filings, limiting conviction signals, but capital allocation patterns show a mix of aggressive reinvestment (Eagle Materials, Movano) and debt-fueled growth (Nextpower, James Hardie). The most actionable intelligence lies in identifying companies with genuine operational leverage versus those masking structural issues with one-time gains or accounting adjustments. Key sectors to watch include energy storage (Energy Vault's explosive growth vs. cash burn) and building materials (James Hardie's AZEK integration vs. Eagle Materials' margin resilience).

36 high priority 36 total filings
· daily

US SEC Trading Suspension Halt Orders — May 19, 2026

The single filing for May 19, 2026, from Bitcoin Depot Inc. (BTM) represents a catastrophic corporate event: a Chapter 11 bankruptcy filing immediately triggering a Nasdaq delisting. This is the highest materiality event possible (10/10), with the company not appealing the delisting, effectively confirming a total equity wipeout for common shareholders. The delisting is driven by both the bankruptcy (Nasdaq Rules 5101, 5110(b), IM-5101-1) and a failure to file a timely Form 10-Q (Rule 5250(c)), indicating severe operational and reporting distress. The company's own filing explicitly warns of a 'significant or complete loss' for security holders. With only one filing in the stream, the dominant theme is a single-entity, high-severity credit and equity risk event with no mitigating factors or positive trends.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 19, 2026

The 40 filings from May 19, 2026, paint a picture of a market bifurcated between aggressive capital management and acute distress. While several firms (STORE Capital, Diversified Energy, Kimbell Royalty) are successfully refinancing debt at lower rates or making accretive acquisitions, a significant cluster of companies is exhibiting classic pre-bankruptcy distress signals. Bitcoin Depot has already filed for Chapter 11 and faces delisting, while TechPrecision, Zoomcar, and Aether Holdings are executing last-resort financing or settlement agreements that signal severe liquidity constraints. The period-over-period data reveals a troubling trend: revenue growth is anemic or negative for many, with net losses widening dramatically (MSP Recovery's loss doubled to $457.8M, Eagle Materials' earnings fell 9% despite record revenue). A wave of dilutive equity offerings (GeoVax, Rapid Micro, Sunshine Biopharma) and distressed debt exchanges (Jaguar Health, InMed) suggests a 'cash-for-equity' cycle is accelerating among micro-cap and clinical-stage biotechs. The most actionable insight is the stark contrast between well-capitalized firms using favorable debt markets to lock in low rates and distressed entities burning through their last options, creating a clear 'haves vs. have-nots' dynamic in the current credit environment.

40 high priority 40 total filings
· daily

US Executive Officer Management Changes SEC — May 19, 2026

This batch of 48 filings reveals a significant wave of leadership transitions across US equities, with notable CEO and CFO appointments at Rogers Corporation, Amerant Bancorp, and A. O. Smith, alongside the unexpected death of TOMI Environmental Solutions' CFO. A key theme is the high level of shareholder dissent on executive compensation, with Skyworks Solutions failing its say-on-pay vote (50.1% against) and several other companies (NOVAGOLD, Permian Resources, ACCO Brands) seeing over 20% opposition. Insider activity is limited to compensation-driven grants, but the lack of open-market purchases suggests caution. Forward-looking catalysts include Immunic's Phase 3 ENSURE trial readout by end of 2026 and Vistagen's new CMO appointment. Capital allocation trends show a focus on equity plan expansions (e.g., Roper Technologies adding 14.15M shares) rather than buybacks or dividends, signaling a bias toward employee retention. The most material event is the Skyworks say-on-pay failure, which could trigger board-level compensation reviews and potential activist interest.

48 high priority 48 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 19, 2026

The 48 filings reveal a heavy focus on annual meeting outcomes and board composition changes, with several high-profile director appointments and executive transitions. Notable trends include significant shareholder dissent on executive compensation and equity plan amendments at multiple companies (e.g., ACCO Brands, Skyworks Solutions, NOVAGOLD), indicating growing investor scrutiny. Several companies appointed new CFOs or CEOs (e.g., A. O. Smith, Rogers Corp, Amerant Bancorp), signaling strategic leadership shifts. The unexpected death of TOMI Environmental's CFO and the resignation of Upstart's board member Jeff Huber highlight succession risks. Overall, the period shows active governance changes with mixed shareholder sentiment, presenting both opportunities and risks for investors.

48 high priority 48 total filings
· daily

US Merger & Acquisition SEC Filings — May 19, 2026

The May 19, 2026, US M&A filing stream reveals a market bifurcated between high-conviction, well-capitalized take-privates and a flurry of SPAC deadline extensions signaling execution risk. The most material event is the $3.1B take-private of Mister Car Wash by Leonard Green & Partners, a definitive bullish signal for the sector that validates asset values. Conversely, the SPAC landscape shows systemic strain: three separate SPACs (Plum, Bayview, EagleRock) disclosed deadline extensions, with Bayview's fourth amendment pushing its closing date over 2.5 years from the original agreement, indicating severe deal fatigue. A major capital markets event was EagleRock Land's $286.6M IPO, a rare positive signal for the Permian Basin asset class. Insider activity was notably absent across the stream, with only one director resignation (Valuence Merger Corp.) that was non-disputative, providing no conviction signals. Forward-looking data points to a catalyst-rich June, with Exascale Labs' COMPUTEX Taipei exhibition and Eton's IMPAVIDO launch in September creating specific alpha opportunities. The aggregate trend shows capital rotating away from SPAC structures toward direct listings and take-privates, with the Mister Car Wash deal demonstrating the premium available for quality assets in a rate-stabilizing environment.

10 high priority 10 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 19, 2026

Overnight filings reveal a market bifurcated between robust operational execution in infrastructure and energy transition versus acute distress in small-cap and commodity-exposed names. Home Depot's mixed quarter, with top-line growth but margin compression, sets a cautious tone for consumer spending, while Eagle Materials' record revenue but declining earnings highlights the 'growth without profit' theme in materials. The most significant corporate actions are the $2.2B acquisition of LiveRamp by Publicis and the $1.35B de-SPAC for Einride, signaling strong M&A appetite in data and green tech. However, a cluster of distressed signals—including Novelis's $84M loss from plant fires, TechPrecision's liquidity crunch, and Natural Alternatives' near-zero gross margin—demand immediate risk review. Insider activity is muted, but the conversion of GitLab's chair from supervoting to common stock is a notable governance event. The forward-looking calendar is packed with catalysts, including Thermon's merger vote, Immunic's Phase 3 readout, and multiple SPAC deadlines, offering both event-driven and turnaround opportunities.

22 high priority 28 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — May 18, 2026

The single contract analyzed, a $605M firm-fixed-price delivery order from DHS/CBP to Fisher Sand & Gravel for border wall construction in San Diego, represents a purely civilian infrastructure award with no defense exposure. The aggregate obligation of $605M is concentrated in a single private entity, limiting direct public equity impact but signaling sustained government investment in border security infrastructure. The highest-conviction signal is neutral, given the private recipient and high cost-overrun risk under a firm-fixed-price structure. Key risks include potential political shifts affecting border wall appropriations and execution risk for the contractor, which may indirectly affect publicly traded subcontractors or material suppliers.

1 total filings
· daily

DHS Homeland Security Contracts — May 18, 2026

This digest covers a single $605 million DHS/CBP contract awarded to privately held Fisher Sand & Gravel for border wall construction in San Diego (2026-2028). The award is entirely civilian (DHS), with no defense-related exposure, and carries a neutral signal strength of 5/10. The highest-conviction signal is the sustained government investment in border infrastructure, but the private nature of the recipient limits direct public equity impact. Key risks include execution risk under a firm-fixed-price structure and potential political volatility around border wall appropriations. Investors should watch for any publicly traded subcontractors or material suppliers that may benefit indirectly.

1 total filings
· daily

New Federal Contractors — May 18, 2026

The single contract analyzed, a $605M firm-fixed-price delivery order from DHS/CBP to private firm Fisher Sand & Gravel for border wall construction in San Diego, represents the entirety of the period's activity. This is a purely civilian award with no defense-related content, signaling sustained government investment in border infrastructure. The neutral signal strength (5/10) and lack of public equity exposure limit direct investment implications, but the contract's size and fixed-price structure create high execution risk for the private contractor. Key risks include political shifts in border policy and potential cost overruns, while opportunities lie in monitoring subcontractor disclosures for indirect public equity exposure.

1 total filings
· daily

Significant Contract Modifications ($10M+) — May 18, 2026

The two contracts analyzed represent $605.6 million in total obligations, both from civilian agencies (DHS and HHS), with zero defense-related awards. The dominant theme is a massive $605 million border wall construction contract awarded to private firm Fisher Sand & Gravel by DHS/CBP, signaling sustained government investment in border infrastructure despite political risks. The second contract, a $542,604 sterile water supply deal with Pfizer, is immaterial to the company's revenue. The highest-conviction signal is the border wall award's potential to benefit publicly traded subcontractors or material suppliers, though direct public equity exposure is absent. Key risks include execution risk under a fixed-price contract and political vulnerability of border wall funding to policy shifts.

2 total filings